Exploring the medical potential and ethical dilemmas of therapeutic cloning technology
Discover how targeting the A3 adenosine receptor (A3AR) with agonists like Cl-IB-MECA can inhibit breast cancer stem cells (BCSCs) and potentially transform breast cancer treatment.
Discover how miniaturized bioreactors are transforming stem cell culture with unprecedented control, scalability, and cost efficiency in regenerative medicine.